Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | HPGD | P15428 | 4/20 | 0.64 |
| ▸ | CASP1 | P29466 | 4/20 | 0.64 |
| ▸ | CASP7 | P55210 | 4/20 | 0.64 |
| ▸ | GLA | P06280 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | STAT6 | P42226 | 1/20 | 0.64 |
| ▸ | ERAP1 | Q9NZ08 | 3/20 | 0.63 |
| ▸ | CA12 | O43570 | 4/20 | 0.59 |
| ▸ | CA9 | Q16790 | 4/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.57 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL888478 | 0.88 | CA12 (0.67) | HSD17B10KDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL1072470 | 0.88 | CA12 (0.67) | HSD17B10KDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL336407 | 0.88 | CA12 (0.67) | HSD17B10KDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL2188796 | 0.88 | CA12 (0.67) | HSD17B10KDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL2778091 | 0.88 | CA12 (0.67) | HSD17B10KDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL165951 | 0.88 | CA12 (0.67) | HSD17B10KDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL8403748 | 0.88 | CA12 (0.67) | HSD17B10KDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL1679606 | 0.88 | CA12 (0.67) | HSD17B10KDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL15124782 | 0.88 | CA12 (0.67) | HSD17B10KDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL7766916 | 0.86 | CA12 (0.65) | HSD17B10KDM4EALDH1A1HPGDCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1341546-B1 | KYBERDRUG AS AUTOVACCINES WITH IMMUNE-REGULATING EFFECTS | SYMBIO HERBORN GROUP GMBH U CO (DE) | 2011-09-21 | — | — | EP | disclosed |
| WO-2002028424-A9 | KYBERDRUG AS AUTOVACCINES WITH IMMUNE-REGULATING EFFECTS | PARADIES H HENRICH (DE) | 2003-09-12 | — | — | WO | disclosed |
| EP-1341546-A2 | KYBERDRUG AS AUTOVACCINES WITH IMMUNE-REGULATING EFFECTS | Paradies, Henrich H. (DE) | 2003-09-10 | — | — | EP | disclosed |
| US-20020155997-A1 | Kyberdrug as autovaccines with immune-regulating effects | SYMBIO HERBORN GROUP GMBH & CO., THE (DE) | 2002-10-24 | — | — | US | disclosed |
| WO-2002028424-A2 | KYBERDRUG AS AUTOVACCINES WITH IMMUNE-REGULATING EFFECTS | PARADIES H HENRICH (DE) | 2002-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020155997-A1 | Kyberdrug as autovaccines with immune-regulating effects | CD74, HAVCR2, ICOS | HSD17B10 3553/4885KDM4E 608/4885ALDH1A1 4046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.